The income statement (statement of earnings) reports on the performance of Eli Lilly & Co., the result of its operating activities.
The assets reports major classes and amounts of resources owned or controlled by Eli Lilly & Co..
The liabilities and stockholders’ equity reports major classes and amounts of external claims on assets and owners’ capital contributions, and other internally generated sources of capital.
The cash flow statement provides information about Eli Lilly & Co. cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on Eli Lilly & Co. balance sheet.
Common-Size Financial Statements
Income statement components (revenues and expenses) shown as percentage of total sales.
Assets components shown as percentage of total assets.
Liabilities and stockholders’ equity components shown as percentage of total liabilities and stockholders’ equity.
Analysis of Financial Ratios
Measures the income of Eli Lilly & Co. relative to its revenues and invested capital.
Examines Eli Lilly & Co. capital structure in terms of the mix of its financing sources and the ability of the firm to satisfy its longer-term debt and investment obligations.
Evaluates revenues and output generated by the Eli Lilly & Co. assets. Operating performance ratios describe the relationship between the Eli Lilly & Co. level of operations and the assets needed to sustain operating activities.
Measures how efficiently Eli Lilly & Co. generates revenues from its investments in fixed or total assets.
An approach to decomposing Eli Lilly & Co. return on equity, return on assets, and net profit margin ratio as the product of other financial ratios.
Relative valuation technique determine the value of Eli Lilly & Co. by comparing it to similar entities (like industry or sector) on the basis of several relative ratios that compare its stock price to relevant variables that affect the stock value, such as earnings, book value, and sales.